To endure seasonally arid conditions, spadefoot toads (Scaphiopus couchii) spend 9-10 months underground each year in a hypometabolic state, termed estivation. Protein tyrosine kinases (PTKs) and phosphatases (PTPs) were evaluated in organs of control and estivating toads to assess their possible role in signal transduction during estivation. Total PTK activity decreased by 27-52 % in liver, lung and skeletal muscle during estivation but rose by 66% in heart. Total PTP activity changed only in liver (55 % decrease) and heart (74 %increase). Analysis of the distribution of PTKs between cytoplasmic and membrane-associated forms showed that estivation-linked changes in both fractions occurred in heart (increase) and liver (decrease) whereas in lung and skeletal muscle only the soluble fraction was affected. PTPs were assessed using both a general substrate (ENDpYINASL) and a substrate (DADEpYLIPQQG) specific for PTPs containing the SH2 binding site; both revealed estivation-associated changes in activities and subcellular distribution of PTPs in all tissues. DEAE-Sephadex chromatography showed multiple forms of skeletal muscle PTKs and PTPs in both soluble and insoluble fractions. Each fraction showed three major peaks of PTK activity, two of which shifted in elution position during estivation. The data show that PTKs and PTPs are modified in an organ-specific fashion during estivation by three mechanisms: changes in total activity, changes in subcellular distribution and possible protein covalent modification.

This content is only available via PDF.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.